K-numberK241411
Device nameWelch Allyn Connex® Spot Monitor; 901058 Vital Signs Monitor Core (CSM)
ApplicantWelch Allyn, Inc.
Product codeMWI
Device classClass II
Decision dateDec 20, 2024
DecisionSubstantially Equivalent
Regulation870.2300
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Welch Allyn Connex Spot Monitor (CSM) is an integrated vital signs monitor used by clinicians to measure noninvasive blood pressure, pulse rate, oxygen saturation (SpO2), body temperature, and respiration rate in neonatal, pediatric, and adult patients. It displays and transmits patient data electronically via USB, Wi-Fi, Bluetooth, or ethernet to hospital information systems and central monitoring stations.

Technological characteristics

The CSM 1.53 adds Masimo pulse oximetry sensing technology for respiration rate measurement from photoplethysmogram (RRp), an additional Braun Pro 6000 infrared thermometer option, additional barcode scanner options, and additional stand/mounting and weight scale options. All updates were implemented through design controls and verified not to impact device safety and efficacy.

Test standards cited

Testing followed IEC 60601-1 (general safety), IEC 60601-1-6 (usability), IEC 60601-1-8 (alarms), ANSI AAMI IEC 80601-2-30 (sphygmomanometers), IEC 80601-2-49 (multifunction monitors), IEC 80601-2-56 (thermometers), ISO 80601-2-61 (pulse oximeters), IEC 62366-1 (usability engineering), IEC 62304 (software lifecycle), and ISO 14971 (risk management), among others.

Substantial equivalence argument

The CSM is substantially equivalent to predicate K142356 because both are integrated vital signs monitors with the same fundamental intended use and function—measuring and displaying patient vital signs in clinical settings. The addition of respiration rate monitoring via Masimo RRp does not constitute a new intended use; it is an additional measurement parameter within the same class of patient physiological monitoring device. All technological updates were implemented through validated design controls and pose no new safety or efficacy concerns relative to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →